Share
Market Research Report

GLOBAL CANCER THERAPEUTICS AND BIOTHERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By ApplicationBlood Cancer · Lung Cancer · Colorectal Cancer · Prostate Cancer · Breast Cancer · Cervical Cancer · Head and Neck Cancer · Giloblastoma · Malignant Meningioma · Mesothelioma · Melanoma · and Others
  • By Therapy TypeChemotherapy · Targeted Therapy · Immunotherapy · Radiation Therapy · Hormone Therapy · Biotherapy · and Others
  • By ApplicationTherapeutics · Drug Discovery · Gene therapy · IVF treatment · Cell therapy · and Research & Development
  • By End UserHospitals & Clinics · Cancer Care Centers · Research Institutes · and Others
  • By GeographyNorth America · Latin America · Asia Pacific · Europe · Middle East · and Africa
  • Published In02 Apr 2026
  • Report CodeCMI7206
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations

  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Application
      • Market Snapshot, By Therapy Type
      • Market Snapshot, By End Users
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)

  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis

  4. Global Cancer Therapeutics and Biotherapeutics Market, By Application, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Blood Cancer
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Lung Cancer
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Colorectal Cancer
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Prostate Cancer
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Cervical Cancer
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Head and Neck Cancer
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Giloblastoma
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Malignant Meningioma
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Mesothelioma
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Melanoma
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

  5. Global Cancer Therapeutics and Biotherapeutics Market, By Therapy Type, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Chemotherapy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Radiation Therapy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Hormone Therapy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Biotherapy
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

  6. Global Cancer Therapeutics and Biotherapeutics Market, By End-User, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospitals & Clinics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Cancer Care Centers
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Research Institutes 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Others
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

  7. Global Cancer Therapeutics and Biotherapeutics Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022–2033
      • Regional Trends

    • North America

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada

    • Latin America

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America

    • Europe

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe

    • Asia Pacific

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Clinical Applications, 2021
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific

    • Middle East

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East

    • Africa

      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa

  8. Competitive Landscape

    • Company Profiles
      • Amgen Inc. 
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bristol-Myers Squibb
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Celgene Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • ELI Lilly and Company
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Hoffmann-La Roche AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • EnGeneIC Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Merck & Co Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Pfizer Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Johnson & Johnson
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • AstraZeneca
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Bristol-Myers Squibb
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Biogen IDEC
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Sanofi
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Novartis AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Roche
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Schering-Plough
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Gilead Sciences
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Takeda Pharmaceutical Company
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies

  9. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map

  10. References and Research Methodology

    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 32 market data tables and 28 figures on "Cancer Therapeutics and Biotherapeutics Market” - Global forecast to 2033